Number of items: 1.
Wolf, S. : Pembrolizumab (Keytruda®) in combination with platinum and fluoropyrimidine based chemotherapyfor the treatment of locally advanced unresectable or metastatic carcinoma of the oesophagus. Oncology Fact Sheet Nr. 54.
Wolf, S. : Pembrolizumab (Keytruda®) in combination with platinum and fluoropyrimidine based chemotherapyfor the treatment of locally advanced unresectable or metastatic carcinoma of the oesophagus. Oncology Fact Sheet Nr. 54.